Literature DB >> 24399397

Mixed pulmonary infection in an immunocompromised patient: a rare case report.

S Qureshi, A Pandey1, T R Sirohi, S R Verma, V Sardana, C Agrawal, A K Asthana, M Madan.   

Abstract

Patients who are immunocompromised are predisposed to a variety of common and uncommon pulmonary infections. We report a case of mixed pulmonary infection by drug resistant tuberculosis with a nocardiosis in a 49-year-old man who was a known case of chronic obstructive pulmonary disease, on prolonged corticosteroid use with diabetes mellitus. Chronic use of corticosteroids is a predisposing factor for opportunistic infections, such as nocardiosis or tuberculosis. Since such a mixed infection is rare, maybe a combined approach to therapy early in the course of disease would be effective in such cases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24399397     DOI: 10.4103/0255-0857.124330

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  3 in total

1.  Polymicrobial pulmonary infection in patients with hematological malignancies: prevalence, co-pathogens, course and outcome.

Authors:  Emilia Hardak; Irit Avivi; Lina Berkun; Ayelet Raz-Pasteur; Noa Lavi; Yuval Geffen; Mordechai Yigla; Ilana Oren
Journal:  Infection       Date:  2016-01-20       Impact factor: 3.553

2.  Pulmonary nocardiosis masquerading renascence of tuberculosis in an immunocompetent host: a case report from Nepal.

Authors:  Priyatam Khadka; Ramesh Bahadur Basnet; Basista Parsad Rijal; Jeevan Bahadur Sherchand
Journal:  BMC Res Notes       Date:  2018-07-17

3.  Aetiology and prognostic risk factors of mortality in patients with pneumonia receiving glucocorticoids alone or glucocorticoids and other immunosuppressants: a retrospective cohort study.

Authors:  Lijuan Li; Steven H Hsu; Xiaoying Gu; Shan Jiang; Lianhan Shang; Guolei Sun; Lingxiao Sun; Li Zhang; Chuan Wang; Yali Ren; Jinxiang Wang; Jianliang Pan; Jiangbo Liu; Cao Bin
Journal:  BMJ Open       Date:  2020-10-27       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.